Skip to main content
Top
Published in: Neurological Sciences 4/2011

01-08-2011 | Case Report

Progressive multifocal leukoencephalopathy following chemotherapy for lung cancer

Authors: Antonio Palmieri, L. Valentinis, S. Bazzano, A. Baldi, F. Orlando, S. Tenaglia, S. D’Anna

Published in: Neurological Sciences | Issue 4/2011

Login to get access

Abstract

Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system caused by the JC virus infection and with a frequent lethal outcome. PML usually occurs in immunocompromised subjects, such as HIV-positive individuals, as well as in other conditions characterized by depletion of cellular immunity, including hematological malignancies, autoimmune diseases, and immunomodulatory therapies. We describe the case of a 76-year-old man affected by advanced non-small cell lung cancer who developed PML after six cycles of carboplatin/gemcitabine therapy, during which a transitory leucopenia developed. The patient deceased a few months after the onset of the symptoms. Chemotherapy appears to be uncommon, but definite condition associated to PML.
Literature
1.
go back to reference Astrom KE, Mancall EL, Richardson EP (1958) Progressive multifocal leuko-encephalopathy: a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin’s disease. Brain 81:93–111PubMedCrossRef Astrom KE, Mancall EL, Richardson EP (1958) Progressive multifocal leuko-encephalopathy: a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin’s disease. Brain 81:93–111PubMedCrossRef
2.
go back to reference Berger JR, Kaszovitz B, Post MJ, Dickinson G (1987) Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med 107:78–87PubMed Berger JR, Kaszovitz B, Post MJ, Dickinson G (1987) Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med 107:78–87PubMed
3.
go back to reference Major EO (2010) Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 61:35–47PubMedCrossRef Major EO (2010) Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 61:35–47PubMedCrossRef
4.
go back to reference Engsig FN, Hansen AB, Omland LH et al (2009) Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis 199(1):77–83PubMedCrossRef Engsig FN, Hansen AB, Omland LH et al (2009) Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis 199(1):77–83PubMedCrossRef
5.
go back to reference Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL (1999) JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 52:253–260PubMed Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL (1999) JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 52:253–260PubMed
6.
go back to reference Gheuens S, Pierone G, Peeters P, Koralnik IJ (2010) Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry 81:247–254PubMedCrossRef Gheuens S, Pierone G, Peeters P, Koralnik IJ (2010) Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry 81:247–254PubMedCrossRef
7.
go back to reference Nagel S, Califano R, Thatcher N, Blackhall F (2007) Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer. Expert Opin Pharmacother 8(18):3265–3275PubMedCrossRef Nagel S, Califano R, Thatcher N, Blackhall F (2007) Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer. Expert Opin Pharmacother 8(18):3265–3275PubMedCrossRef
8.
go back to reference Lee SM, James LE, Qian W et al (2009) Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer. Thorax 64(1):75–80PubMedCrossRef Lee SM, James LE, Qian W et al (2009) Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer. Thorax 64(1):75–80PubMedCrossRef
Metadata
Title
Progressive multifocal leukoencephalopathy following chemotherapy for lung cancer
Authors
Antonio Palmieri
L. Valentinis
S. Bazzano
A. Baldi
F. Orlando
S. Tenaglia
S. D’Anna
Publication date
01-08-2011
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 4/2011
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-011-0494-7

Other articles of this Issue 4/2011

Neurological Sciences 4/2011 Go to the issue